The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

Phase 1 Completed 46 enrolled Addpharma Inc.

RandomizedCrossoverOpen-labelTreatment

Summary

The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.

Timeline

Start: 2025-03-21
Primary completion: 2025-04-25
Completion: 2025-05-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AD-1151	Unknown	—	Oral
Subject	AD-115A	Unknown	—	Oral

The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

Summary

Timeline

Drugs

Indications